54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY)

✍ Scribed by C. Sarrazin; S. Schwendy; B. Möller; N. Dikopoulos; P. Buggisch; J. Encke; G. Teuber; T. Goeser; R. Thimme; H. Klinker; W.O. Boecher; E. Schulte-Frohlinde; R. Prinzing; T. Berg; S. Zeuzem

• Book ID: 117378142
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 69 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(10)60056-6